Columbia Care Inc
F:3LP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Haier Smart Home Co Ltd
HKEX:6690
|
CN |
|
S
|
Sichuan Baicha Baidao Industrial Co Ltd
HKEX:2555
|
CN |
|
Artnet AG
XETRA:ART
|
DE |
Columbia Care Inc
Capital Expenditures
Columbia Care Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Columbia Care Inc
F:3LP
|
Capital Expenditures
-$72.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Capital Expenditures
-$4.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Capital Expenditures
-$1.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Capital Expenditures
-$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-6%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Capital Expenditures
-$4.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Capital Expenditures
-$10.8B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-21%
|
|
Columbia Care Inc
Glance View
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. The company is headquartered in New York City, New York. The company went IPO on 2019-04-29. The firm is engaged cultivating, manufacturing and providing medical and adult use cannabis products and related services with licenses in over 18 the United States jurisdictions and the European Union (EU). The firm operates facilities including dispensaries and cultivation and manufacturing facilities. The firm operates as the original providers of medical cannabis in the United States and continues to deliver a patient-centered medicinal cannabis operation. The firm offers products spanning flower, edibles, oils, and tablets, and manufactures brands including Seed & Strain, Amber and Platinum Label Cannabidiol (CBD) products. The company develops products which comprised of a variety of medical and adult-use form factors, including but not limited to formulations, precision manufactured dosing and cannabis flower and flower-derived products.
See Also
What is Columbia Care Inc's Capital Expenditures?
Capital Expenditures
-72.7m
USD
Based on the financial report for Dec 31, 2022, Columbia Care Inc's Capital Expenditures amounts to -72.7m USD.
What is Columbia Care Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-31%
Over the last year, the Capital Expenditures growth was 38%. The average annual Capital Expenditures growth rates for Columbia Care Inc have been 2% over the past three years , -31% over the past five years .
